Genome-based identification of diagnostic molecular markers for human lung carcinomas by PLS-DA

Comput Biol Chem. 2005 Jun;29(3):183-95. doi: 10.1016/j.compbiolchem.2005.04.005.

Abstract

Partial least squares discriminant analysis (PLS-DA) provides a sound statistical basis for the selection of a limited number of gene transcripts most effective in discriminating different lung tumoral histotypes. The potentialities of the PLS-DA approach are pointed out by its ability to identify genes which, according to current knowledge, are considered molecular markers for colon cancer diagnostics and classification. Indeed application of PLS-DA to in vivo data allowed identification of a set of genes able to discriminate primary lung tumours from colon metastases.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers, Tumor / genetics*
  • Carcinoma / diagnosis*
  • Discriminant Analysis
  • Gene Expression Profiling*
  • Humans
  • Least-Squares Analysis
  • Lung Neoplasms / diagnosis*

Substances

  • Biomarkers, Tumor